Unique ID issued by UMIN | UMIN000034084 |
---|---|
Receipt number | R000038847 |
Scientific Title | Validation of a new tele-monitoring modality (TeleOX) in patients with chronic obstructive pulmonary disease |
Date of disclosure of the study information | 2018/09/11 |
Last modified on | 2022/03/14 10:07:35 |
Validation of a new tele-monitoring modality (TeleOX) in patients with chronic obstructive pulmonary disease
Validation of the performance of TeleOX
Validation of a new tele-monitoring modality (TeleOX) in patients with chronic obstructive pulmonary disease
Validation of the performance of TeleOX
Japan |
Chronic obstructive pulmonary disease
Pneumology |
Others
NO
To examine the accuracy of respiratory rate measurement by TeleOX during wakefulness and sleep in patients with chronic obstructive pulmonary disease
Others
To compare the respiratory rate measured by TeleOX and by polysomnography
Confirmatory
Others
Not applicable
Correlation between the respiratory rates measured by TeleOX and those measured by polysomnography during wakefulness and sleep
1.Changes of respiratory rate and percutaneous carbon dioxide partial pressure by oxygen administration
2.Correlation between percutaneous oxygen saturation or percutaneous carbon dioxide partial pressure and data evaluated by transthoracic echocardiography
3.Correlation between respiratory rate and other clinical characteristics
Observational
20 | years-old | <= |
85 | years-old | >= |
Male and Female
1.Male or female patients (aged 20-85 years)
2.Treatment drugs do not matter.
3.Patients with chronic obstructive pulmonary disease followed at the Department of Respiratory Medicine in Kyoto University Hospital, and suspected to have sleep-related breathing disorders by the examination with pulse-oximeter (PULSOX-300i) or Watch-PAT in the setting of outpatient clinic.
1.Patients are excluded if they are in active phase of acute exacerbation of chronic obstructive pulmonary disease or respiratory infections; new onset pneumothorax or exacerbation of chronic pneumothorax; or unstable state due to the worsening of other comorbidities (e.g. heart failure, bronchial asthma, and renal failure).
2.Patients are excluded if they are already treated with nasal continuous positive airway pressure therapy for obstructive sleep apnea syndrome.
20
1st name | Tomohiro |
Middle name | |
Last name | Handa |
Graduate School of Medicine, Kyoto University
Department of Advanced Medicine for Respiratory Failure
606-8507
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto
075-366-7689
hanta@kuhp.kyoto-u.ac.jp
1st name | Tomohiro |
Middle name | |
Last name | Handa |
Graduate School of Medicine, Kyoto University
Department of Advanced Medicine for Respiratory Failure
606-8507
54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto
075-366-7689
hanta@kuhp.kyoto-u.ac.jp
Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University
TEIJIN PHARMA
Profit organization
Kyoto University Graduate School and Faculty of Medicine Kyoto University Hospital Ethics Committe
Yoshida Konoe-cho, Sakyo-ku, Kyoto
075-753-4680
ethcom@kuhp.kyoto-u.ac.jp
NO
2018 | Year | 09 | Month | 11 | Day |
Unpublished
10
Completed
2018 | Year | 09 | Month | 10 | Day |
2018 | Year | 12 | Month | 18 | Day |
2018 | Year | 12 | Month | 19 | Day |
2021 | Year | 12 | Month | 18 | Day |
2022 | Year | 01 | Month | 31 | Day |
2022 | Year | 01 | Month | 31 | Day |
2022 | Year | 01 | Month | 31 | Day |
This study is a prospective observational study in patients with chronic obstructive pulmonary diesase.
2018 | Year | 09 | Month | 10 | Day |
2022 | Year | 03 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038847